Trial Profile
Prospective, placebo-controlled study of atomoxetine and midodrine in patients with severe autonomic failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary) ; Midodrine
- Indications Orthostatic hypotension
- Focus Pharmacodynamics; Therapeutic Use
- 06 Nov 2015 New trial record